Get Sample Pages - AI In Cancer Diagnostic Market Grow at CAGR of 40.1% by 2026

Global Artificial Intelligence (AI) in Cancer Diagnostic Market Research Report: Forecast (2021-2026)

By Application (Screening & Diagnosis, Tumor Identification, Treatment, Surveillance) By Cancer Type (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cance......r, Other (Pancreatic, Skin, Blood, etc.)) By End User (Hospitals, Medical Research Institutes, Diagnostics Centers, Contract Research Organizations) Read more

Healthcare
Aug 2021
Pages 232
Report Format: PDF, Excel, PPT

The integration of artificial intelligence technology, such as machine learning, predictive analysis, etc., in a complete process of cancer treatment in a human body from diagnosis to post-treatment surveillance is referred to as AI in Cancer Diagnostics.

The Global Artificial Intelligence (AI) in Cancer Diagnostic Market is anticipated to grow at a CAGR of around 40.1% during the forecast period, i.e., 2021-26, says MarkNtel Advisors in their research report. The rising number of cancer cases worldwide is the most prominent factor contributing to the market growth. Additionally, the rapidly growing number of startup companies providing services on almost the same base all across the globe drives the market growth.

The research report “Global Artificial Intelligence (AI) in Cancer Diagnostic Market Analysis, 2021” also states that the automated capabilities of AI offer the potential to enhance diagnostics and treatment quality. Hence, the demand for integrating artificial intelligence technology in cancer diagnostics is significantly increasing, which would fuel the overall market growth in the coming years.

Report Coverage	Details
Study Period	Historical Data: 2016-19
	Base Year: 2020
	Forecast Period: 2021-26
CAGR (2021-2026)	40.1%
Regions Covered	North America: USA, Canada
	Europe: Germany, UK, France, Italy, Spain, Russia
	Asia-Pacific: China, India, Japan, South Korea, Australia and Others
	South America: Brazil, Mexico
	Middle East & Africa: Saudi Arabia, South Africa
Key Companies Profiled	Pfizer, Therapixel, Sophia Genetics, Freenome, Tempus, Janssen Pharmaceutica, Path AI, Google Deep Mind, IBM, Microsoft, Cerner Corporation, RaySearch Laboratories, Flatiron, Oncology Analytics, Inc, Oncora Medical, and Others.
Unit Denominations	USD Million/Billion

Impact of COVID-19 Outbreak on Global Artificial Intelligence (AI) in Cancer Diagnostic Market

Last year, almost all economies in the world faced around a 30% slump. The usage of AI in cancer diagnostics also experienced a slight dip due to the shift in the healthcare industry's focus towards solving the current problem of the Coronavirus pandemic. The COVID-19 crisis impacted cancer patient visits for treatment.

Further, the pandemic resulted in delays in diagnosis, suspension of screening programs, health system closures, and reduced access to a healthcare facility. These factors led to a short-term decline in cancer incidence, increasing advanced-stage diagnoses, and cancer mortality.

Introduction
1. Product Definition
2. Research Process
3. Market Segmentation
4. Assumptions
Preface
Executive Summary
Impact of COVID-19 on Global Artificial Intelligence (AI) in Cancer Diagnostic Market
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Dynamics
1. Growth Drivers
2. Challenges
3. Impact Analysis
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Policies and Standards
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Trends & Insights
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Hotspot & Opportunities
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Key Strategic Imperatives for Success & Growth
Global Artificial Intelligence (AI) in Cancer Diagnostics Market Startup Ecosystem
1. Entrepreneurial Activity
2. Year on Year Funding Received
3. Funding Received by Top Companies
4. Key Investors Active in the Market
5. Series Wise Funding Received
  1. Seed Funding
  2. Angel Investing
  3. Venture
  4. Others
Global Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. By Revenues
2. Market Share & Analysis
  1. By Application
    1. Screening & Diagnosis
    2. Tumour Identification
    3. Treatment
    4. Surveillance
  2. By Cancer Type
    1. Breast Cancer
    2. Prostate Cancer
    3. Lung Cancer
    4. Colorectal Cancer
    5. Cervical Cancer
    6. Other (Pancreatic, Skin, Blood, etc.)
  3. By End User
    1. Hospitals
    2. Medical Research Institutes
    3. Diagnostics Centres
    4. Contract Research Organizations
  4. By Region
    1. North America
    2. Latin America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
  5. By Company
    1. Competition Characteristics
    2. Market Share & Analysis
    3. Competitor Placement in MarkNtel Quadrant
North America Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Application
  2. By Cancer Type
  3. By End User
  4. By Country
    1. The US
    2. Canada
3. The US Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Application
    2. By Cancer Type
    3. By End User
4. Canada Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Application
    2. By Cancer Type
    3. By End User
Latin America Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Application
  2. By Cancer Type
  3. By End User
  4. By Country
    1. Brazil
    2. Mexico
    3. Others
3. Brazil Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
4. Mexico Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
Europe Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Application
  2. By Cancer Type
  3. By End User
  4. By Country
    1. The UK
    2. Italy
    3. Germany
    4. France
    5. Spain
    6. Russia
3. The UK Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
4. Italy Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
5. Germany Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
6. France Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
7. Spain Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
8. Russia Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
Middle East & Africa Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Application
  2. By Cancer Type
  3. By End User
3. By Country
  1. Saudi Arabia
  2. South Africa
  3. Rest of the Middle East & Africa
4. Saudi Arabia Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
5. South Africa Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
Asia-Pacific Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
1. Market Size & Analysis
  1. Revenues
2. Market Share & Analysis
  1. By Application
  2. By Cancer Type
  3. By End User
3. By Country
  1. China
  2. Japan
  3. India
  4. South Korea
  5. Australia
  6. Others
4. China Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
5. Japan Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
6. India Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Application
    2. By Cancer Type
    3. By End User
7. South Korea Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
8. Australia Artificial Intelligence (AI) in Cancer Diagnostic Market Outlook, 2016-2026F
  1. Market Size & Analysis
    1. Revenues
  2. Market Share & Analysis
    1. By Cancer Type
Competition Outlook
1. Competition Matrix
  1. Product/ Solution Portfolio
  2. Target Markets
  3. Target End Users
  4. Research & Development
  5. Strategic Alliances
  6. Strategic Initiatives
2. Company Profiles of Top Companies (Business Description, Product Segments, Business Segments, Financials, Strategic Alliances/ Partnerships, Future Plans)
  1. Pfizer
  2. Therapixel
  3. Sophia Genetics
  4. Freenome
  5. Tempus
  6. Janssen Pharmaceutica
  7. Path AI
  8. Google Deep Mind
  9. IBM
  10. Microsoft
  11. Cerner Corporation
  12. RaySearch Laboratories
  13. Flatiron
  14. Oncology Analytics, Inc
  15. Oncora Medical
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO GET THE FREE SAMPLE PAGES

Name *

Email ID *

Country *